Baidu
map

J Clin Pharmacol:胃肠道症状或影响自闭症患者药物治疗有效性

2014-09-04 伊文 生物谷

近日,刊登在国际杂志The Journal of Clinical Pharmacology上的一篇研究报告中,来自国外的科学家们通过研究表示,许多自闭症的儿童或成人往往会引发一些胃肠道的疾病,而且胃肠道疾病的症状通常也会影响自闭症患者对药物的吸收并且降低药效。 自闭症,又名孤独症,其是广泛性发育障碍的一种亚型,以男性患者多见,主要表现为不同程度的言语发育障碍、人际交往障碍等症状;约有3/4

近日,刊登在国际杂志The Journal of Clinical Pharmacology上的一篇研究报告中,来自国外的科学家们通过研究表示,许多自闭症的儿童或成人往往会引发一些胃肠道的疾病,而且胃肠道疾病的症状通常也会影响自闭症患者对药物的吸收并且降低药效。

自闭症,又名孤独症,其是广泛性发育障碍的一种亚型,以男性患者多见,主要表现为不同程度的言语发育障碍、人际交往障碍等症状;约有3/4的患者伴有明显的精神发育迟滞,部分患儿在一般性智力落后的背景下某方面具有较好的能力。

据推测大约有35%的自闭症患者都在服用至少一种精神病药物来帮助控制其自闭症的症状,而这项研究也正式分析了自闭症个体的胃肠道症状和自闭症药物的药效之间的潜在关系,研究者呼吁,改变当前针对自闭症患者的药物模式或许可以更有效地治疗患者的自闭症。

最后研究人员Maria Valdovinos表示,不得不承认当前存在很多变量影响着患者对药物的反应,而揭示胃肠道疾病对自闭症患者的影响或许更为重要,未来我们还需要进行更为深入的研究来揭示胃肠道疾病和自闭症药物之间的具体分子关联。

原始出处:


Heitzer AM1, Job MA, Pandit NK, Valdovinos MG.Should clinical trial research of psychotropic medication in autism control for gastrointestinal symptoms?J Clin Pharmacol. 2014 May 1. doi: 10.1002/jcph.324. [Epub ahead of print]


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1995907, encodeId=00a9199590edb, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 23 00:24:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787154, encodeId=cdad1e8715417, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Tue Jun 16 14:24:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908173, encodeId=d1a219081e34d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Dec 31 04:24:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788158, encodeId=d42a1e88158f3, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jan 29 08:24:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346186, encodeId=34e01346186ad, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527564, encodeId=7ece152e564d7, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568198, encodeId=8ce315681980e, content=<a href='/topic/show?id=40de83346a3' target=_blank style='color:#2F92EE;'>#胃肠道症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83346, encryptionId=40de83346a3, topicName=胃肠道症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eede15326817, createdName=yinhl1983, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=)]
    2015-07-23 yb6560
  2. [GetPortalCommentsPageByObjectIdResponse(id=1995907, encodeId=00a9199590edb, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 23 00:24:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787154, encodeId=cdad1e8715417, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Tue Jun 16 14:24:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908173, encodeId=d1a219081e34d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Dec 31 04:24:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788158, encodeId=d42a1e88158f3, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jan 29 08:24:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346186, encodeId=34e01346186ad, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527564, encodeId=7ece152e564d7, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568198, encodeId=8ce315681980e, content=<a href='/topic/show?id=40de83346a3' target=_blank style='color:#2F92EE;'>#胃肠道症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83346, encryptionId=40de83346a3, topicName=胃肠道症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eede15326817, createdName=yinhl1983, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=)]
    2015-06-16 jj000001
  3. [GetPortalCommentsPageByObjectIdResponse(id=1995907, encodeId=00a9199590edb, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 23 00:24:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787154, encodeId=cdad1e8715417, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Tue Jun 16 14:24:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908173, encodeId=d1a219081e34d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Dec 31 04:24:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788158, encodeId=d42a1e88158f3, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jan 29 08:24:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346186, encodeId=34e01346186ad, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527564, encodeId=7ece152e564d7, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568198, encodeId=8ce315681980e, content=<a href='/topic/show?id=40de83346a3' target=_blank style='color:#2F92EE;'>#胃肠道症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83346, encryptionId=40de83346a3, topicName=胃肠道症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eede15326817, createdName=yinhl1983, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1995907, encodeId=00a9199590edb, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 23 00:24:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787154, encodeId=cdad1e8715417, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Tue Jun 16 14:24:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908173, encodeId=d1a219081e34d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Dec 31 04:24:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788158, encodeId=d42a1e88158f3, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jan 29 08:24:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346186, encodeId=34e01346186ad, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527564, encodeId=7ece152e564d7, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568198, encodeId=8ce315681980e, content=<a href='/topic/show?id=40de83346a3' target=_blank style='color:#2F92EE;'>#胃肠道症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83346, encryptionId=40de83346a3, topicName=胃肠道症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eede15326817, createdName=yinhl1983, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1995907, encodeId=00a9199590edb, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 23 00:24:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787154, encodeId=cdad1e8715417, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Tue Jun 16 14:24:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908173, encodeId=d1a219081e34d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Dec 31 04:24:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788158, encodeId=d42a1e88158f3, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jan 29 08:24:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346186, encodeId=34e01346186ad, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527564, encodeId=7ece152e564d7, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568198, encodeId=8ce315681980e, content=<a href='/topic/show?id=40de83346a3' target=_blank style='color:#2F92EE;'>#胃肠道症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83346, encryptionId=40de83346a3, topicName=胃肠道症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eede15326817, createdName=yinhl1983, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1995907, encodeId=00a9199590edb, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 23 00:24:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787154, encodeId=cdad1e8715417, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Tue Jun 16 14:24:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908173, encodeId=d1a219081e34d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Dec 31 04:24:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788158, encodeId=d42a1e88158f3, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jan 29 08:24:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346186, encodeId=34e01346186ad, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527564, encodeId=7ece152e564d7, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568198, encodeId=8ce315681980e, content=<a href='/topic/show?id=40de83346a3' target=_blank style='color:#2F92EE;'>#胃肠道症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83346, encryptionId=40de83346a3, topicName=胃肠道症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eede15326817, createdName=yinhl1983, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=)]
    2014-09-06 xiongke014
  7. [GetPortalCommentsPageByObjectIdResponse(id=1995907, encodeId=00a9199590edb, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Thu Jul 23 00:24:00 CST 2015, time=2015-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787154, encodeId=cdad1e8715417, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Tue Jun 16 14:24:00 CST 2015, time=2015-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908173, encodeId=d1a219081e34d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Dec 31 04:24:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788158, encodeId=d42a1e88158f3, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jan 29 08:24:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346186, encodeId=34e01346186ad, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527564, encodeId=7ece152e564d7, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568198, encodeId=8ce315681980e, content=<a href='/topic/show?id=40de83346a3' target=_blank style='color:#2F92EE;'>#胃肠道症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83346, encryptionId=40de83346a3, topicName=胃肠道症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eede15326817, createdName=yinhl1983, createdTime=Sat Sep 06 02:24:00 CST 2014, time=2014-09-06, status=1, ipAttribution=)]

相关资讯

戏剧或有助治疗自闭症

在戏剧游戏中寻找另一个“自我”自闭症谱系障碍(Autism-spectrum disorders,ASD)是一组有神经基础的广泛性发展障碍,主要以社会交往障碍及交流障碍为特点的发育障碍性疾病,同时还伴有行为受限、兴趣狭窄、重复或呈刻板模式等特征。 自闭症谱系障碍包括自闭症(Autism)、阿斯伯格综合症、雷特综合征、儿童瓦解性精神障碍等亚类。从症状的严重程度而言,自闭症是上述各亚类中最

Transl Psychiatry:基因与环境相互作用导致自闭症

从第一例自闭症患者——美国男孩唐纳德于1943年被确诊开始,人们就开始了针对自闭症(别称“雨人”)的研究。不过,无论治疗方式怎样“更新换代”,自闭症的病因却一直是科学界无法达成共识的未知数。 自闭症的发病机理在早期的研究中,曾被单纯地认为是外界因素导致的心理疾病。随着自闭症研究的逐渐深入,鉴于自闭症发病时期早、遗传特性明显,科学家目前普遍认为自闭症是主要由遗传物质所控制,同时受环境因

EHP:美研究证实农药与自闭症有关

加州一项研究23日指出,怀孕期间居住在使用农药的农场附近,孩子罹患自闭症的风险高出2/3.这份发表在《环境健康展望期刊》(Environmental Health Perspectives)的研究,研究居住在使用农药的场所附近与后代罹患自闭症的关联性,不过未显示因果关係.自闭症是一种神经发展疾病,严重程度从轻微到重度都有,近年来比例攀升。美国当局表示,美国每68名儿童就有1人罹患自闭症。这项最新研

Hum Mol Genet:FABPs缺陷可能与精神分裂症和自闭症有关

日本RIKEN脑科学研究所(RIKEN Brain Science Institute)的神经科学家们报道称,脂肪酸结合蛋白(FABPs)缺陷,可能有助于解释一些精神分裂症和自闭症谱系障碍的病理学。在发现患者的FABPs突变后,Takeo Yoshikawa带领的研究小组确定,小鼠中的Fabps破坏,使其行为看起来像疾病患者。这项工作表明,FABPs缺陷可能

PNAS:催产素水平或与儿童社会行为缺陷有关

研究发现,有社会行为缺陷的一些儿童表现出了血液催产素水平低以及催产素受体基因的突变,但是催产素功能被削弱不仅仅限于自闭症谱系障碍(ASD)的儿童。催产素促进动物与人类的社会行为,而研究提示催产素调控的削弱可能是人类的自闭症谱系障碍(ASD)的一个基础原因。Karen J. Parker及其同事测量了193名3到13岁儿童的催产素血液水平,这些儿童一些被诊断为患有自闭症谱系障碍(

Nat Genet:自闭症遗传风险大多来自常见基因变异

最近,美国国立卫生研究院(NIH)资助的一项研究发现,大多数的自闭症遗传风险来自于常见基因变异,而不是罕见基因变异或自发故障。在这项迄今最大的研究中,遗传可能性比其他风险因素更加重要。 西奈山伊坎医学院(ISMMS)的Joseph Buxbaum博士解释说:“基因变异可能引起了大约60%的自闭症,常见的变异包含大多数的遗传结构。虽然每个变异单独只发挥很小的影响,但这些常见的遗传

Baidu
map
Baidu
map
Baidu
map